CRYSTAL FORM OF NEUROKININ-1 ANTAGONIST PRODRUG COMPOUND
The present disclosure relates to a crystal form of a neurokinin-1 antagonist prodrug compound. Specifically, the present disclosure relates to a novel crystal form of a compound represented by formula I and a preparation method. The novel crystal form of the present disclosure has a good physicoche...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure relates to a crystal form of a neurokinin-1 antagonist prodrug compound. Specifically, the present disclosure relates to a novel crystal form of a compound represented by formula I and a preparation method. The novel crystal form of the present disclosure has a good physicochemical property and better facilitates clinical treatment. |
---|